Related Experiment Video
Updated: May 7, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Probiotic-conditioned microbiota from preterm infants modulate immune response to pathogen challenge in a
Justine Smout1,2, Till-Robin Lesker3, Lisa Hoenicke1
1Department of Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Insights
Multistrain probiotics altered preterm infants' gut microbes, leading to reduced immune cell development in mice. This may increase susceptibility to early-life infections, highlighting complex probiotic effects.
Area of Science:
- Microbiology
- Immunology
- Neonatal Research
Background:
- Early-life microbial exposures profoundly influence immune system development and long-term health.
- The PRIMAL trial showed probiotics altered preterm infant gut microbiota but didn't impact sepsis rates, leaving immunological effects unclear.
Purpose of the Study:
- To investigate the immunological consequences of probiotic-induced gut microbiota shifts in very preterm infants.
- To determine how these altered microbial communities affect immune cell development and infection susceptibility.
Main Methods:
- Germ-free mice were colonized with human gut microbiota from probiotic- or placebo-treated preterm infants.
- Immune cell populations were analyzed at steady-state and following enteropathogenic *Escherichia coli* challenge.
- Microbiota stability and transmission across generations were assessed.
Main Results:
- Probiotic-conditioned microbiota led to reduced innate immune cell populations in mouse pups, especially in the colon.
- Adaptive immune subsets were less affected by the probiotic-altered microbiota.
- Mice with probiotic-conditioned microbiota showed impaired growth and bacterial clearance upon *E. coli* infection.
Conclusions:
- Probiotic-induced shifts in human gut microbiota can attenuate immune cell development and compromise early-life infection outcomes in a murine model.
- These findings reveal complex, context-dependent effects of probiotics on the neonatal microbiota-immune axis.
- Mechanistic insights are provided into how early-life interventions in preterm infants may influence infection susceptibility.
Abstract:
Early-life host-microbe interactions critically shape immune development, lifelong homeostasis, and disease susceptibility. The PRIMAL trial (Priming Immunity at the Beginning of Life) demonstrated that multistrain probiotics shifted the gut microbiota of very preterm infants toward eubiosis without affecting sepsis incidence, yet the immunological consequences remained unresolved. To explore this, we colonized germ-free female mice with fecal samples from probiotic- or placebo-treated preterm infants from the PRIMAL trial. Microbiota composition was vertically transmitted and stable across generations. At steady-state, 3-week-old pups colonized with probiotic-conditioned microbiota exhibited markedly reduced populations of innate immune cells, particularly in the colon, with subtler effects in the small intestine and spleen, while adaptive immune subsets were less affected. Upon enteropathogenic Escherichia coli challenge at day 5, pups harboring probiotic-conditioned microbiota displayed reduced growth and impaired bacterial clearance, correlating with diminished numbers of key innate immune cell populations. These findings demonstrate that probiotic-driven shifts in human-derived microbial communities can attenuate immune cell development in mice and alter early-life infection outcomes. Our study underscores the complex, context-dependent effects of probiotics on the neonatal microbiota-immune axis and provides mechanistic insight into how interventions in preterm infants may influence susceptibility to infection.
More Related Videos
07:32A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
Published on: August 30, 2019
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Development of Human Microbiota
Introduction to the Human Microbiota
Development of the Oral Microbiota
Gut-Brain Axis
Probiotics